Literature DB >> 28083595

Mitochondrial dynamics as regulators of cancer biology.

Andrew Paul Trotta1,2, Jerry Edward Chipuk3,4,5,6,7.   

Abstract

Mitochondria are dynamic organelles that supply energy required to drive key cellular processes, such as survival, proliferation, and migration. Critical to all of these processes are changes in mitochondrial architecture, a mechanical mechanism encompassing both fusion and fragmentation (fission) of the mitochondrial network. Changes to mitochondrial shape, size, and localization occur in a regulated manner to maintain energy and metabolic homeostasis, while deregulation of mitochondrial dynamics is associated with the onset of metabolic dysfunction and disease. In cancers, oncogenic signals that drive excessive proliferation, increase intracellular stress, and limit nutrient supply are all able to alter the bioenergetic and biosynthetic requirements of cancer cells. Consequently, mitochondrial function and shape rapidly adapt to these hostile conditions to support cancer cell proliferation and evade activation of cell death programs. In this review, we will discuss the molecular mechanisms governing mitochondrial dynamics and integrate recent insights into how changes in mitochondrial shape affect cellular migration, differentiation, apoptosis, and opportunities for the development of novel targeted cancer therapies.

Entities:  

Keywords:  Apoptosis; Cancer; Differentiation; Migration; Mitochondrial dynamics; Oncogenic signaling

Mesh:

Year:  2017        PMID: 28083595      PMCID: PMC5419868          DOI: 10.1007/s00018-016-2451-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  145 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Translocation of SenP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis.

Authors:  Rodolfo Zunino; Emélie Braschi; Liqun Xu; Heidi M McBride
Journal:  J Biol Chem       Date:  2009-05-01       Impact factor: 5.157

Review 3.  New insights into the function and regulation of mitochondrial fission.

Authors:  Hidenori Otera; Naotada Ishihara; Katsuyoshi Mihara
Journal:  Biochim Biophys Acta       Date:  2013-02-20

4.  Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease.

Authors:  Hongxia Wang; Pingping Song; Lei Du; Weili Tian; Wen Yue; Min Liu; Dengwen Li; Bin Wang; Yushan Zhu; Cheng Cao; Jun Zhou; Quan Chen
Journal:  J Biol Chem       Date:  2011-02-03       Impact factor: 5.157

Review 5.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

6.  Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart.

Authors:  Atsushi Hoshino; Yuichiro Mita; Yoshifumi Okawa; Makoto Ariyoshi; Eri Iwai-Kanai; Tomomi Ueyama; Koji Ikeda; Takehiro Ogata; Satoaki Matoba
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice.

Authors:  Junko Wakabayashi; Zhongyan Zhang; Nobunao Wakabayashi; Yasushi Tamura; Masahiro Fukaya; Thomas W Kensler; Miho Iijima; Hiromi Sesaki
Journal:  J Cell Biol       Date:  2009-09-14       Impact factor: 10.539

Review 8.  Mitochondrial fission - a drug target for cytoprotection or cytodestruction?

Authors:  Ayeshah A Rosdah; Jessica K Holien; Lea M D Delbridge; Gregory J Dusting; Shiang Y Lim
Journal:  Pharmacol Res Perspect       Date:  2016-04-21

9.  Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.

Authors:  Frances E Lennon; Gianguido C Cianci; Rajani Kanteti; Jacob J Riehm; Qudsia Arif; Valeriy A Poroyko; Eitan Lupovitch; Wickii Vigneswaran; Aliya Husain; Phetcharat Chen; James K Liao; Martin Sattler; Hedy L Kindler; Ravi Salgia
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

10.  Mitofusin 1 is degraded at G2/M phase through ubiquitylation by MARCH5.

Authors:  Yong-Yea Park; Hyeseong Cho
Journal:  Cell Div       Date:  2012-12-20       Impact factor: 5.130

View more
  81 in total

Review 1.  MDM2 and mitochondrial function: One complex intersection.

Authors:  Camila Rubio-Patiño; Andrew Paul Trotta; Jerry Edward Chipuk
Journal:  Biochem Pharmacol       Date:  2018-11-01       Impact factor: 5.858

2.  T-Cell Intracellular Antigens and Hu Antigen R Antagonistically Modulate Mitochondrial Activity and Dynamics by Regulating Optic Atrophy 1 Gene Expression.

Authors:  Isabel Carrascoso; José Alcalde; Carmen Sánchez-Jiménez; Paloma González-Sánchez; José M Izquierdo
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

Review 3.  Mitochondrial dynamics and their potential as a therapeutic target.

Authors:  B N Whitley; E A Engelhart; S Hoppins
Journal:  Mitochondrion       Date:  2019-06-19       Impact factor: 4.160

4.  Paris Saponin II inhibits colorectal carcinogenesis by regulating mitochondrial fission and NF-κB pathway.

Authors:  Meihong Chen; Ke Ye; Biying Zhang; Qiao Xin; Ping Li; Ah-Ng Kong; Xiaodong Wen; Jie Yang
Journal:  Pharmacol Res       Date:  2018-11-22       Impact factor: 7.658

5.  AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.

Authors:  Miao Qi; Dan Dai; Jin Liu; Zhongqi Li; Panpan Liang; Yue Wang; Lu Cheng; Yihong Zhan; Zhifeng An; Yaoyao Song; Yana Yang; Xiaohui Yan; Hui Xiao; Huanjie Shao
Journal:  Oncogene       Date:  2020-01-31       Impact factor: 9.867

Review 6.  Mitochondrial Morphofunction in Mammalian Cells.

Authors:  Elianne P Bulthuis; Merel J W Adjobo-Hermans; Peter H G M Willems; Werner J H Koopman
Journal:  Antioxid Redox Signal       Date:  2018-11-29       Impact factor: 8.401

7.  Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction.

Authors:  Wei-Bin Zheng; Yang-Jia Li; Yang Wang; Jie Yang; Can-Can Zheng; Xiao-Hui Huang; Bin Li; Qing-Yu He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

8.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 9.  Links between mitochondrial retrograde response and mitophagy in pathogenic cell signalling.

Authors:  Daniela Strobbe; Soumya Sharma; Michelangelo Campanella
Journal:  Cell Mol Life Sci       Date:  2021-02-23       Impact factor: 9.261

Review 10.  Targeting acidity in cancer and diabetes.

Authors:  Robert J Gillies; Christian Pilot; Yoshinori Marunaka; Stefano Fais
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-30       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.